A large body of scientific evidence now indicates that the accumulation of cellular HSP70s, especially HSPA1A, in lung alveolar cells is beneficial against ARDS-induced lung damage, as in the case of the most severe COVID-19 pathologies. This evidence concerns the gene HSPA1A and COVID-19.